Literature DB >> 20645830

Antimicrobial activity of the extracts and physalin D from Physalis alkekengi and evaluation of antioxidant potential of physalin D.

S Helvaci1, G Kökdil, M Kawai, N Duran, G Duran, A Güvenç.   

Abstract

Physalis alkekengi L. (Solanaceae) is a popular plant in traditional European and Chinese folk medicine, and it has been reported to have many ethnopharmacological properties including antifungal, anti-cough, anti-inflammatory, analgesic, and febricide activities. Some active components from Physalis species have been investigated. However, no antimicrobial activity studies on extracts and physalins of P. alkekengi have been carried out. In this study, we attempted to identify the possible antimicrobial activities of the methanol extract from aerial parts of P. alkekengi and the dichloromethane extract from calyces of the plant. The extracts were tested against five Gram-positive and five Gram-negative bacteria and five Candida species by using disk diffusion and broth microdilution methods. The extracts were fractionated to isolate physalins using chromatographic techniques, and physalin D was isolated from the extracts. The structure of the compound was elucidated on the basis of (1)H-NMR spectroscopic study, and confirmed by comparison with a reference sample and literature data. Results indicated that all the extracts and physalin D were characterized by antibacterial action, especially against Gram-positive bacteria, with MIC values between 32 and 128 microg/mL. The methanol extract had moderate activity against fungi at MICs ranging from 128 to 512 microg/mL, but the dichloromethane extract and physalin D had low activity against fungi at MICs ranging from 256 to 512 microg/mL. Additionally, the antioxidant activity of physalin D was evaluated by qualitative DPPH (1,1-diphenyl-2-picrylhydrazyl) radical and TBA (thiobarbituric acid) assays. Physalin D showed low antioxidant activity with an IC(50) value of >or= 10 +/- 2.1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20645830     DOI: 10.3109/13880200903062606

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  10 in total

1.  An Evidence-Based Review on Wound Healing Herbal Remedies From Reports of Traditional Persian Medicine.

Authors:  Ayda Hosseinkhani; Maryam Falahatzadeh; Elahe Raoofi; Mohammad M Zarshenas
Journal:  J Evid Based Complementary Altern Med       Date:  2016-06-22

2.  Anti-Inflammatory Effect of Three Isolated Compounds of Physalis alkekengi var. franchetii (PAF) in Lipopolysaccharide-Activated RAW 264.7 Cells.

Authors:  Hyun-Jung Park; Hyun Soo Shim; Ah-Reum Han; Eun-Kyoung Seo; Kyu-Ri Kim; Bong Hee Han; Insop Shim
Journal:  Curr Issues Mol Biol       Date:  2022-03-21       Impact factor: 2.976

3.  Bioactivity-guided fractionation of the triglyceride-lowering component and in vivo and in vitro evaluation of hypolipidemic effects of Calyx seu Fructus Physalis.

Authors:  Yihui Yang; Xianmei Piao; Mingyu Zhang; Xiaodan Wang; Bing Xu; Jiuxin Zhu; Zhiwei Fang; Yunlong Hou; Yanjie Lu; Baofeng Yang
Journal:  Lipids Health Dis       Date:  2012-03-14       Impact factor: 3.876

4.  In vitro studies on the relationship between the antioxidant activities of some berry extracts and their binding properties to serum albumin.

Authors:  Jacek Namiesnik; Kann Vearasilp; Alina Nemirovski; Hanna Leontowicz; Maria Leontowicz; Pawel Pasko; Alma Leticia Martinez-Ayala; Gustavo A González-Aguilar; Milan Suhaj; Shela Gorinstein
Journal:  Appl Biochem Biotechnol       Date:  2014-01-22       Impact factor: 2.926

5.  Triterpenoids Extracted From Antrodia cinnamomea Mycelia Attenuate Acute Alcohol-Induced Liver Injury in C57BL/6 Mice via Suppression Inflammatory Response.

Authors:  Yange Liu; Zhuqian Wang; Fange Kong; Lesheng Teng; Xiaoyi Zheng; Xingkai Liu; Di Wang
Journal:  Front Microbiol       Date:  2020-07-03       Impact factor: 5.640

6.  Physalis alkekengi var. franchetii Extracts Exert Antitumor Effects on Non-Small Cell Lung Cancer and Multiple Myeloma by Inhibiting STAT3 Signaling.

Authors:  Yufei Fu; Fanfan Zhu; Zhongjun Ma; Bin Lv; Xi Wang; Chunyan Dai; Xiaoqiong Ma; Pei Liu; Hang Lv; Xin Chen; Zhe Chen; Li Shen
Journal:  Onco Targets Ther       Date:  2021-01-12       Impact factor: 4.147

Review 7.  Natural Products from Physalis alkekengi L. var. franchetii (Mast.) Makino: A Review on Their Structural Analysis, Quality Control, Pharmacology, and Pharmacokinetics.

Authors:  Jing Yang; Yanping Sun; Feng Cao; Bingyou Yang; Haixue Kuang
Journal:  Molecules       Date:  2022-01-21       Impact factor: 4.411

Review 8.  Plant-Derived Nanoscale-Encapsulated Antioxidants for Oral and Topical Uses: A Brief Review.

Authors:  Seong-Hyeon Kim; Young-Chul Lee
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

9.  Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.

Authors:  Fanfan Zhu; Chunyan Dai; Yufei Fu; Jacky F C Loo; Dajin Xia; Sizhi P Gao; Zhongjun Ma; Zhe Chen
Journal:  Oncotarget       Date:  2016-02-23

Review 10.  Anti-Obesity Effects of Polyphenol Intake: Current Status and Future Possibilities.

Authors:  Mariarosaria Boccellino; Stefania D'Angelo
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.